Friday 26 June, 2009
Healthcare Locums
Holding(s) in Company
RNS Number : 5707U Healthcare Locums PLC 26 June 2009
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
|
Healthcare Locums plc
|
|
2 Reason for the notification (please tick the appropriate box or boxes):
|
|
An acquisition or disposal of voting rights
|
YES
|
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
|
N/A
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
|
N/A
|
|
An event changing the breakdown of voting rights
|
N/A
|
|
Other (please specify):
|
|
N/A
|
|
3. Full name of person(s) subject to the notification obligation:
|
AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies
|
|
4. Full name of shareholder(s) (if different from 3.):
|
|
|
5. Date of the transaction and date on which the threshold is crossed or reached:
|
18 June 2009
|
|
6. Date on which issuer notified:
|
19 June 2009
|
|
7. Threshold(s) that is/are crossed or reached:
|
5%
|
|
8. Notified details:
|
|
A: Voting rights attached to shares
|
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering transaction
|
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
% of voting rights
|
|
Direct
|
Direct
|
Indirect
|
Direct
|
Indirect
|
|
Ordinary Shares
|
5,373,150
|
5,373,150
|
0
|
0
|
5,151,130
|
0.00
|
4.94
|
|
GB00B0MD8242
|
|
B: Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Expiration
date
|
Exercise/ Conversion Period
|
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
|
% of voting
rights
|
|
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Exercise price
|
Expiration date
|
Exercise/
Conversion period
|
Number of voting rights instrument refers to
|
% of voting rights
|
|
|
|
|
|
|
Nominal
|
Delta
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights
|
Percentage of voting rights
|
|
5,151,130
|
4.94%
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
|
|
Name of the Company/Fund
|
Number of shares
|
% of issued share capital
|
|
AXA France
Indirect
|
350,000
|
0.33566
|
|
AXA IM UK
Indirect
|
4,801,130
|
4.60439
|
|
|
|
|
|
Total Direct
Total Indirect
TOTAL
|
0
5,151,130
5,151,130
|
0.00000
4.94005
4.94005
|
|
|
Proxy Voting:
|
|
10. Name of the proxy holder:
|
|
|
11. Number of voting rights proxy holder will cease to hold:
|
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
|
|
13. Additional information:
|
|
|
14. Contact name:
|
Kyere Tabiri
|
|
15. Contact telephone number:
|
0207 003 1510
|
This information is provided by RNS
The company news service from the London Stock Exchange END HOLPUUGCQUPBURQ
|
|